Blog
RSS FeedPosted by Michael Wonder on 14 Jan 2020
Roche aims to 'underwhelm' on SMA drug price to challenge rivals
14 January 2020 - Swiss drug maker Roche plans to price its oral spinal muscular atrophy drug risdiplam aggressively to challenge ...
Posted by Michael Wonder on 08 Jan 2020
Why Humira’s price keeps rising despite FDA approval of generic competition
8 January 2020 - The FDA has approved five generic versions of Humira — the world’s biggest-selling drug with global ...
Posted by Michael Wonder on 19 Dec 2019
North America trade pact deals rare setback to big pharma
19 December 2019 - A revamped North American trade deal nearing passage in Congress gives both the White House and ...
Posted by Michael Wonder on 18 Dec 2019
Trump Administration takes historic steps to lower U.S. prescription drug prices
18 December 2019 - Proposed rule could allow certain prescription drugs to be imported from Canada; draft guidance explains how manufacturers ...
Posted by Michael Wonder on 14 Dec 2019
FDA issues new analysis linking greater generic competition and lower generic drug prices
13 December 2019 - Greater competition among generic drug makers is associated with lower generic drug prices, according to a new ...
Posted by Michael Wonder on 26 Nov 2019
Teva, drug makers in talks with U.S. to end generics probes
26 November 2019 - Deferred prosecution agreements among resolutions discussed. ...
Posted by Michael Wonder on 22 Nov 2019
Speaker Pelosi’s drug pricing plan could result in 56 fewer new medicines over 10 years
21 November 2019 - International reference pricing provisions in plan would decimate development of innovative medicines by nearly 90%. ...
Posted by Michael Wonder on 21 Nov 2019
Drug for ultra rare disease comes with ultra high price tag
21 November 2019 - Givlaari’s net price will be $442,000 after discounts included. ...
Posted by Michael Wonder on 21 Nov 2019
Doctors who helped develop heart drug now balk at $225,000/year price
19 November 2019 - Wearing a revolutionary-era tricorn hat, doctor Mathew Maurer stood at a lectern in front of an ...
Posted by Michael Wonder on 19 Nov 2019
In a rare political move, prominent biotech venture capitalists speak out against Pelosi’s drug pricing bill
18 November 2019 - A group of top biotech venture capitalists are issuing a stark warning to Congress: They won’t ...
Posted by Michael Wonder on 18 Nov 2019
National MS Society responds to price of new Biogen/Alkermes MS medication Vumerity
13 November 2019 - The FDA recently approved a new medication for relapsing MS, Vumerity, by Biogen and Alkermes. ...
Posted by Michael Wonder on 14 Nov 2019
To drive down insulin prices, WHO will certify generic versions
13 November 2019 - About 80 million people with diabetes around the world need the hormone, and half of them can’t ...
Posted by Michael Wonder on 06 Nov 2019
One shot drug to end Sicilian curse comes at $1.8 million cost
5 November 2019 - A new targeted gene therapy shows the promise and pitfalls of medical advances. ...
Posted by Michael Wonder on 25 Oct 2019
Amgen to make Repatha (evolocumab) available exclusively at its lower list price option in 2020
24 October 2019 - Repatha original list price option will be discontinued effective 31 December 2019. ...
Posted by Michael Wonder on 23 Oct 2019
Vertex prices cystic fibrosis combo treatment at $311,000-per-year
22 October 2019 - Vertex Pharmaceuticals has priced its three-drug combination for cystic fibrosis (CF) at $311,503 per year, after winning ...